Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 713 of 6351
-
Could a single pill replace two after heart implant? major trial seeks safer stroke prevention
Disease control OngoingThe primary objective is to demonstrate the safety and effectiveness of two monotherapy regimens versus dual antiplatelet (DAPT) therapy following post-implant with the WATCHMAN FLX Pro device in a commercial clinical setting.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for diabetic nerve pain: phase 3 trial launches
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail of four drugs hopes to fight Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis is a multicenter Phase 1b/2 clinical trial investigating the efficacy and safety of a combination regimen of Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab in treatment-naïve patients with unresectable, locally advanced, or metastatic biliary tract cancers (BTC), i…
Sponsor: CHA University • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
New combo therapy offers hope for cancer patients who Can't breathe
Disease control Recruiting nowThis phase I/II trial studies the side effects of interstitial photodynamic therapy following palliative radiotherapy and how well it works in treating patients with inoperable malignant central airway obstruction. Patients who have advanced stage cancer tumors in the lung can of…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New weekly shot helps shed pounds in obesity trial
Disease control CompletedA Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living …
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Common antifungal drug shows promise against esophageal cancer
Disease control Recruiting nowEsophageal cancer, which has a low 5-year overall survival rate (\<20%) is increasing in incidence. Previous studies have shown that Hedgehog, AKT, and angiogenic signaling pathways are activated in a significant number of esophageal cancers. Itraconazole, a widely used anti-fung…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New MRI scan could predict pancreatic cancer treatment success
Diagnosis Recruiting nowThis study evaluates an investigational scan called hyperpolarized carbon-13 pyruvate magnetic resonance imaging (MRI) in assessing treatment response in patients with pancreatic ductal carcinoma (PDA) that has spread to nearby tissue or lymph nodes (locally advanced) or that has…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New 3D imaging could sharpen cancer diagnosis
Diagnosis Recruiting nowThis project aims to employ a sample preprocessing system in conjunction with three-dimensional imaging techniques to generate morphologically more complete, high-resolution datasets for lung and colorectal cancers. Building on systematic experimental optimization of the preproce…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New hope for adults with HLH: gentler treatment combo under study
Disease control Recruiting nowThis phase II trial tests the effects of ruxolitinib in combination with a de-intensified HLH-94 drug regimen has on patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH), a disorder caused by dysregulated immune responses (that is, immune responses that are too …
Phase 2 • Sponsor: Jerry Lee, MD, MSc, MPhil • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Spinal shock therapy: new device aims to restore bladder function in paralyzed veterans
Disease control Recruiting nowThe investigators are looking to determine the safety and efficacy of non-invasive transcutaneous spinal cord stimulation (TSCS) in promoting recovery of lower urinary tract (LUT), bowel, sexual, and cardiovascular function, as well as spasticity in individuals with subacute and …
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could an arthritis drug shrink dangerous brain aneurysms?
Disease control Recruiting nowPatients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for …
Phase 1/2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a wearable ultrasound device ease knee arthritis pain without pills?
Symptom relief CompletedThe purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering fr…
Phase 2 • Sponsor: ZetrOZ, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
A new wash could outsmart spine surgery infections without the seroma risk
Disease control Recruiting nowVarious spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomy…
Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Smart pillbox sends alerts to keep HIV treatment on track
Disease control OngoingThe investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if t…
Phase 3 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
AI and ultrasound join forces to detect hidden muscle decline in the ICU
Diagnosis CompletedThe aim of this observational case-control study is to investigate, whether artificial intelligence can detect ultrasound-derived imaging characteristics typical for intensive care unit-acquired weakness. The main questions it aims to answer are: 1. Is the evaluation of specific…
Sponsor: Jena University Hospital • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Rewriting traumatic panic memories: a new therapy on trial
Symptom relief CompletedThe current project consists of two studies investigating the phenomenological characteristics, centrality levels, and traumatic symptoms of panic attack memories, while testing the effectiveness of the Imagery Rescripting (ImRs) intervention in the treatment of panic disorder. …
Sponsor: İmge eylem yılmaz namlı • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a Drug-Coated balloon keep heart arteries open for a decade?
Knowledge-focused By invitation onlyThis ambiprospective observational study evaluates the long-term safety and efficacy of Paclitaxel Drug-Coated Balloon (DCB) angioplasty in approximately 5,000 patients with de novo coronary artery lesions in large vessels. By combining retrospective historical data with a prospe…
Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can antibiotic paste heal bone infections without IV drips?
Disease control CompletedThe goal of this clinical trial is to look at the outcomes of patients who have had bone infection of their feet treated with a licensed antibiotic paste. The main question it aims to answer is: • How does the bone infection heal in response to the antibiotic paste? Participant…
Sponsor: Mid and South Essex NHS Foundation Trust • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a new test cut unnecessary biopsies for HPV-Positive women?
Diagnosis OngoingA prospective study assessing TS accuracy in HR-HPV+ women, influencing factors, and 1-year follow-up of false-positives versus biopsy.
Sponsor: Affiliated Hospital of Nantong University • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Can a new injection breathe life into COPD treatment?
Disease control CompletedThis multicentre retrospective cohort study describes lung function and patient-reported outcomes in adults with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who received add-on dupilumab in routine clinical care at six Italian centres. During the study p…
Sponsor: Azienda Ospedaliera di Perugia • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC